全文获取类型
收费全文 | 214182篇 |
免费 | 69125篇 |
国内免费 | 2407篇 |
学科分类
医药卫生 | 285714篇 |
出版年
2024年 | 516篇 |
2023年 | 4805篇 |
2022年 | 1191篇 |
2021年 | 4418篇 |
2020年 | 11085篇 |
2019年 | 12940篇 |
2018年 | 15632篇 |
2017年 | 16987篇 |
2016年 | 18518篇 |
2015年 | 18480篇 |
2014年 | 25418篇 |
2013年 | 26108篇 |
2012年 | 8888篇 |
2011年 | 8980篇 |
2010年 | 17944篇 |
2009年 | 18394篇 |
2008年 | 7415篇 |
2007年 | 4710篇 |
2006年 | 7285篇 |
2005年 | 4321篇 |
2004年 | 3593篇 |
2003年 | 2575篇 |
2002年 | 2743篇 |
2001年 | 4516篇 |
2000年 | 3654篇 |
1999年 | 3428篇 |
1998年 | 3647篇 |
1997年 | 3461篇 |
1996年 | 3364篇 |
1995年 | 3215篇 |
1994年 | 1952篇 |
1993年 | 1565篇 |
1992年 | 1357篇 |
1991年 | 1405篇 |
1990年 | 1052篇 |
1989年 | 1176篇 |
1988年 | 1009篇 |
1987年 | 834篇 |
1986年 | 882篇 |
1985年 | 711篇 |
1984年 | 543篇 |
1983年 | 517篇 |
1982年 | 510篇 |
1981年 | 395篇 |
1980年 | 356篇 |
1979年 | 309篇 |
1978年 | 330篇 |
1977年 | 399篇 |
1975年 | 281篇 |
1972年 | 282篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
The circadian rhythm in humans is determined by the central clock located in the hypothalamus’s suprachiasmatic nucleus, and it synchronizes the peripheral clocks in other tissues. Circadian clock genes and clock-controlled genes exist in almost all cell types. They have an essential role in many physiological processes, including lipid metabolism in the liver, regulation of the immune system, and the severity of infections. In addition, circadian rhythm genes can stimulate the immune response of host cells to virus infection. Hepatitis B virus (HBV) infection is the leading cause of liver disease and liver cancer globally. HBV infection depends on the host cell, and hepatocyte circadian rhythm genes are associated with HBV replication, survival, and spread. The core circadian rhythm proteins, REV-ERB and brain and muscle ARNTL-like protein 1, have a crucial role in HBV replication in hepatocytes. In addition to influencing the virus’s life cycle, the circadian rhythm also affects the pharmacokinetics and efficacy of antiviral vaccines. Therefore, it is vital to apply antiviral therapy at the appropriate time of day to reduce toxicity and improve the effectiveness of antiviral treatment. For these reasons, understanding the role of the circadian rhythm in the regulation of HBV infection and host responses to the virus provides us with a new perspective of the interplay of the circadian rhythm and anti-HBV therapy. Therefore, this review emphasizes the importance of the circadian rhythm in HBV infection and the optimization of antiviral treatment based on the circadian rhythm-dependent immune response. 相似文献
9.
10.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献